Early recognition and preventive care for persons being at risk for type 2 diabetes in community pharmacies in Bavaria, Germany

Early recognition and preventive care for persons being at risk for type 2 diabetes in community pharmacies in Bavaria, Germany - GLICEMIA

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00006585

Enrollment

1112

Registered

2014-09-17

Start date

2013-10-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E11

Interventions

Group 1: Subjects, who have an increased risk for diabetes (at least 7 points in the diabetes risk questionnaire FINDRISC), participate in a structured lifestyle intervention program (three individual

Eligibility

Sex/Gender

All

Age

35 Years to No maximum

Inclusion criteria

Inclusion criteria: increased risk for diabetes (FINDRISC score at least 7 points), ability to give written informed consent

Exclusion criteria

Exclusion criteria: diabetes, cancer, pregnancy, participation in a clinical trial 30 days prior to enrollment

Design outcomes

Primary

Measure	Time frame
FINDRISC score: Is there a significant difference of the change of the FINDRISC score between the intervention and the control group after 12 months?	—

Secondary

Measure	Time frame
1) Weight loss (e.g., of at least 5% after 12 months in case of overweight at baseline) 2) Change of the capillary blood glucose level after 12 months 3) Change of the systolic and diastolic blood pressure after 12 months (non-invasive measurement) 4) Change of the physical activity after 12 months 5) Change of the quality of life after 12 months (SF-12 questionnaire) For every secondary endpoint the comparison between the groups was analyzed.	—

Measure

Time frame

1) Weight loss (e.g., of at least 5% after 12 months in case of overweight at baseline) 2) Change of the capillary blood glucose level after 12 months 3) Change of the systolic and diastolic blood pressure after 12 months (non-invasive measurement) 4) Change of the physical activity after 12 months 5) Change of the quality of life after 12 months (SF-12 questionnaire) For every secondary endpoint the comparison between the groups was analyzed.

—

Countries

Germany

Contacts

Public ContactKarin Schmiedel

WIPIG - Wissenschaftliches Institut für Prävention im Gesundheitswesen der Bayerischen Landesapothekerkammer

info@wipig.de089 - 92 62 16

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026